Credit Agricole’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Credit Agricole’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,264	Closed	-$90K	–	1654
2016 Q3	$90K	Buy	+2,264	New	+$25.3K	﹤0.01%	1529

Credit Agricole's TBRA Position: Q4 2016 in Review

Credit Agricole sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 2,264 shares — an estimated $90K sold.

Credit Agricole first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $90K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Credit Agricole reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Credit Agricole sold 2,264 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $90K.
Credit Agricole first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Credit Agricole's Tobira Therapeutics, Inc. Common Stock position peaked at $90K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Credit Agricole's 13F filing for Q4 2016, filed 13 Feb 2017.